Treatment patterns, clinical outcomes and health care costs associated with her2-positive breast cancer with central nervous system metastases: a French ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2013-10-31

AUTHORS

Sandrine Baffert, Paul Cottu, Youlia M Kirova, Florence Mercier, Cécile Simondi, Thomas Bachelot, Emilie Le Rhun, Christelle Levy, Maya Gutierrez, Nicolas Madranges, Cristian Moldovan, Bruno Coudert, Dominique Spaëth, Daniel Serin, François-Emery Cotté, Laure Benjamin, Cathie Maillard, Sabine Laulhere-Vigneau, Isabelle Durand-Zaleski

ABSTRACT

BackgroundThe population of patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer (BC) who develop central nervous system (CNS) metastases is growing. Treatment strategies in this population are highly diverse. The objective of the study was to assess health care costs for the management of HER2 positive BC with CNS metastases.MethodsThis multicentre, retrospective, observational study was conducted on HER2-positive BC patients diagnosed with CNS metastases between 2006 and 2008. Data were extracted from patient medical records to estimate health care resource use. A partitioned estimator was used to adjust censoring costs by use of the Kaplan-Meier survival estimate.Results218 patients were included and costs were estimated for 200 patients. The median time to detection of CNS metastases was 37.6 months. The first metastatic event involved the CNS in 39 patients, and this was the unique first metastatic site in 31 of these patients. Two years following diagnosis of CNS metastases, 70.3% of patients had died. The mean per capita cost of HER2-positive BC with CNS metastases in the first year following diagnosis was €35,735 [95% CI: 31,716-39,898]. The proportion of costs attributed to expensive drugs and those arising from hospitalisation were in the same range.ConclusionA range of individualised disease management strategies are used in HER2-positive BC patients with CNS metastases and the treatments used in the first months following diagnosis are expensive. The understanding of cost drivers may help optimise healthcare expenditure and inform the development of appropriate prevention policies. More... »

PAGES

456

Journal

TITLE

BMC Health Services Research

ISSUE

1

VOLUME

13

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1472-6963-13-456

DOI

http://dx.doi.org/10.1186/1472-6963-13-456

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1014130335

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24176086


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Central Nervous System Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "France", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genes, erbB-2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Health Care Costs", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kaplan-Meier Estimate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Patient Outcome Assessment", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Public Health, Health Economics unit, Institut Curie, 26 rue d\u2019Ulm, 75005, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.418596.7", 
          "name": [
            "Department of Public Health, Health Economics unit, Institut Curie, 26 rue d\u2019Ulm, 75005, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Baffert", 
        "givenName": "Sandrine", 
        "id": "sg:person.01002330441.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002330441.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Institut Curie, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.418596.7", 
          "name": [
            "Department of Medical Oncology, Institut Curie, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cottu", 
        "givenName": "Paul", 
        "id": "sg:person.0731533007.65", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0731533007.65"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiation Oncology, Institut Curie, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.418596.7", 
          "name": [
            "Department of Radiation Oncology, Institut Curie, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kirova", 
        "givenName": "Youlia M", 
        "id": "sg:person.01310327270.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310327270.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Stat Process, Port-Mort, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Stat Process, Port-Mort, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mercier", 
        "givenName": "Florence", 
        "id": "sg:person.01013525105.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013525105.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Research, Institut Curie, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.418596.7", 
          "name": [
            "Department of Clinical Research, Institut Curie, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Simondi", 
        "givenName": "C\u00e9cile", 
        "id": "sg:person.0631562437.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0631562437.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Centre L\u00e9on B\u00e9rard, Lyon, France", 
          "id": "http://www.grid.ac/institutes/grid.418116.b", 
          "name": [
            "Department of Medical Oncology, Centre L\u00e9on B\u00e9rard, Lyon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bachelot", 
        "givenName": "Thomas", 
        "id": "sg:person.014333462034.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014333462034.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Neurology, Medical Oncology Department, Oscar Lambret Center, Lille, France and Neuro-oncology, University Hospital, Lille, France", 
          "id": "http://www.grid.ac/institutes/grid.410463.4", 
          "name": [
            "Neurology, Medical Oncology Department, Oscar Lambret Center, Lille, France and Neuro-oncology, University Hospital, Lille, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Le Rhun", 
        "givenName": "Emilie", 
        "id": "sg:person.01335025472.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01335025472.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Centre Fran\u00e7ois Baclesse, Caen, France", 
          "id": "http://www.grid.ac/institutes/grid.476192.f", 
          "name": [
            "Department of Medical Oncology, Centre Fran\u00e7ois Baclesse, Caen, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Levy", 
        "givenName": "Christelle", 
        "id": "sg:person.01117111471.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01117111471.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Institut Curie, Saint-Cloud, France", 
          "id": "http://www.grid.ac/institutes/grid.418596.7", 
          "name": [
            "Department of Medical Oncology, Institut Curie, Saint-Cloud, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gutierrez", 
        "givenName": "Maya", 
        "id": "sg:person.01252205456.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252205456.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Institut Bergoni\u00e9, Bordeaux, France", 
          "id": "http://www.grid.ac/institutes/grid.476460.7", 
          "name": [
            "Department of Medical Oncology, Institut Bergoni\u00e9, Bordeaux, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Madranges", 
        "givenName": "Nicolas", 
        "id": "sg:person.01210731760.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210731760.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Centre Henri Becquerel, Rouen, France", 
          "id": "http://www.grid.ac/institutes/grid.418189.d", 
          "name": [
            "Department of Medical Oncology, Centre Henri Becquerel, Rouen, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Moldovan", 
        "givenName": "Cristian", 
        "id": "sg:person.01315023242.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01315023242.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Centre JF Leclerc, Dijon, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Medical Oncology, Centre JF Leclerc, Dijon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Coudert", 
        "givenName": "Bruno", 
        "id": "sg:person.0727212634.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727212634.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Centre d\u2019Oncologie de Gentilly, Nancy, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Medical Oncology, Centre d\u2019Oncologie de Gentilly, Nancy, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Spa\u00ebth", 
        "givenName": "Dominique", 
        "id": "sg:person.01136617563.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01136617563.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Institut Sainte Catherine, Avignon, France", 
          "id": "http://www.grid.ac/institutes/grid.482015.a", 
          "name": [
            "Department of Medical Oncology, Institut Sainte Catherine, Avignon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Serin", 
        "givenName": "Daniel", 
        "id": "sg:person.0746022136.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0746022136.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmaco-Epidemiology and Health Outcomes Research, GlaxoSmithKline, Marly-le-Roi, France", 
          "id": "http://www.grid.ac/institutes/grid.476503.3", 
          "name": [
            "Department of Pharmaco-Epidemiology and Health Outcomes Research, GlaxoSmithKline, Marly-le-Roi, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cott\u00e9", 
        "givenName": "Fran\u00e7ois-Emery", 
        "id": "sg:person.0655344765.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0655344765.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmaco-Epidemiology and Health Outcomes Research, GlaxoSmithKline, Marly-le-Roi, France", 
          "id": "http://www.grid.ac/institutes/grid.476503.3", 
          "name": [
            "Department of Pharmaco-Epidemiology and Health Outcomes Research, GlaxoSmithKline, Marly-le-Roi, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Benjamin", 
        "givenName": "Laure", 
        "id": "sg:person.0777101415.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0777101415.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ceri Medical, Garches, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Ceri Medical, Garches, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maillard", 
        "givenName": "Cathie", 
        "id": "sg:person.01047403102.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047403102.58"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ceri Medical, Garches, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Ceri Medical, Garches, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Laulhere-Vigneau", 
        "givenName": "Sabine", 
        "id": "sg:person.01115516302.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01115516302.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "H\u00f4pital Henri-Mondor, Cr\u00e9teil, France", 
          "id": "http://www.grid.ac/institutes/grid.412116.1", 
          "name": [
            "H\u00f4pital Henri-Mondor, Cr\u00e9teil, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Durand-Zaleski", 
        "givenName": "Isabelle", 
        "id": "sg:person.01327533357.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327533357.46"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/bjc.2011.531", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016621851", 
          "https://doi.org/10.1038/bjc.2011.531"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-005-9034-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049624536", 
          "https://doi.org/10.1007/s10549-005-9034-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-007-9601-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050250912", 
          "https://doi.org/10.1007/s10549-007-9601-0"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2013-10-31", 
    "datePublishedReg": "2013-10-31", 
    "description": "BackgroundThe population of patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer (BC) who develop central nervous system (CNS) metastases is growing. Treatment strategies in this population are highly diverse. The objective of the study was to assess health care costs for the management of HER2 positive BC with CNS metastases.MethodsThis multicentre, retrospective, observational study was conducted on HER2-positive BC patients diagnosed with CNS metastases between 2006 and 2008. Data were extracted from patient medical records to estimate health care resource use. A partitioned estimator was used to adjust censoring costs by use of the Kaplan-Meier survival estimate.Results218 patients were included and costs were estimated for 200 patients. The median time to detection of CNS metastases was 37.6\u00a0months. The first metastatic event involved the CNS in 39 patients, and this was the unique first metastatic site in 31 of these patients. Two years following diagnosis of CNS metastases, 70.3% of patients had died. The mean per capita cost of HER2-positive BC with CNS metastases in the first year following diagnosis was \u20ac35,735 [95% CI: 31,716-39,898]. The proportion of costs attributed to expensive drugs and those arising from hospitalisation were in the same range.ConclusionA range of individualised disease management strategies are used in HER2-positive BC patients with CNS metastases and the treatments used in the first months following diagnosis are expensive. The understanding of cost drivers may help optimise healthcare expenditure and inform the development of appropriate prevention policies.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/1472-6963-13-456", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1327417", 
        "issn": [
          "1472-6963"
        ], 
        "name": "BMC Health Services Research", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "13"
      }
    ], 
    "keywords": [
      "HER2-positive breast cancer", 
      "HER2-positive BC patients", 
      "central nervous system metastases", 
      "nervous system metastases", 
      "CNS metastases", 
      "positive breast cancer", 
      "breast cancer", 
      "health care costs", 
      "BC patients", 
      "observational study", 
      "care costs", 
      "health care resource use", 
      "human epidermal growth factor receptor 2", 
      "Kaplan-Meier survival estimates", 
      "epidermal growth factor receptor 2", 
      "first metastatic event", 
      "multicentre observational study", 
      "growth factor receptor 2", 
      "care resource use", 
      "first metastatic site", 
      "population of patients", 
      "patients' medical records", 
      "factor receptor 2", 
      "appropriate prevention policies", 
      "MethodsThis multicentre", 
      "Results218 patients", 
      "median time", 
      "metastatic sites", 
      "treatment patterns", 
      "clinical outcomes", 
      "medical records", 
      "proportion of costs", 
      "treatment strategies", 
      "receptor 2", 
      "patients", 
      "metastatic events", 
      "metastasis", 
      "expensive drugs", 
      "first month", 
      "healthcare expenditures", 
      "survival estimates", 
      "diagnosis", 
      "capita costs", 
      "cancer", 
      "first year", 
      "prevention policies", 
      "months", 
      "multicentre", 
      "hospitalisation", 
      "population", 
      "CNS", 
      "years", 
      "resource use", 
      "cost drivers", 
      "disease management strategies", 
      "study", 
      "drugs", 
      "outcomes", 
      "treatment", 
      "management strategies", 
      "same range", 
      "proportion", 
      "use", 
      "management", 
      "records", 
      "strategies", 
      "events", 
      "expenditure", 
      "objective", 
      "patterns", 
      "data", 
      "development", 
      "sites", 
      "detection", 
      "time", 
      "cost", 
      "understanding", 
      "means", 
      "range", 
      "estimates", 
      "drivers", 
      "policy", 
      "estimator"
    ], 
    "name": "Treatment patterns, clinical outcomes and health care costs associated with her2-positive breast cancer with central nervous system metastases: a French multicentre observational study", 
    "pagination": "456", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1014130335"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1472-6963-13-456"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24176086"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1472-6963-13-456", 
      "https://app.dimensions.ai/details/publication/pub.1014130335"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:38", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_586.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/1472-6963-13-456"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1472-6963-13-456'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1472-6963-13-456'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1472-6963-13-456'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1472-6963-13-456'


 

This table displays all metadata directly associated to this object as RDF triples.

390 TRIPLES      21 PREDICATES      128 URIs      116 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1472-6963-13-456 schema:about N0000cc2f98c4441eb1a9bd6368ce5a07
2 N2eda9e33036849509fe7fe7ca92e5ecc
3 N42a2712343a044018ab0f4f5779a0b36
4 N46fcc627b584410998e34890c3fb05cb
5 N82b5a69c69bd40c09ab30720aed3deb2
6 N874ced525a6541c3bab9a7816e53e5bc
7 N8d60a8f7d29b43639bb6a18d4b7eeecd
8 N9c4da5f5390e467ebf651abf7373b166
9 N9ed2cd9f107d428682a4949569201488
10 Na4bfb33bc3d842c2ad29a363f37f570c
11 Nd1a71a205a6443fb9528cb24a67bdfd6
12 Nd99cc0d04b934f72b49f3d73555d1906
13 Ne9668abb72434c238af58c0af8edd34f
14 Nf97c76774a60414d9192807f104a2581
15 Nf982149327f74558a249fdaa10e59b8b
16 Nfd981e20c0fc4b488668bd8f967f9c9d
17 anzsrc-for:11
18 anzsrc-for:1112
19 anzsrc-for:1117
20 schema:author Nfe65380f4d11424ca566801b35f88141
21 schema:citation sg:pub.10.1007/s10549-005-9034-6
22 sg:pub.10.1007/s10549-007-9601-0
23 sg:pub.10.1038/bjc.2011.531
24 schema:datePublished 2013-10-31
25 schema:datePublishedReg 2013-10-31
26 schema:description BackgroundThe population of patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer (BC) who develop central nervous system (CNS) metastases is growing. Treatment strategies in this population are highly diverse. The objective of the study was to assess health care costs for the management of HER2 positive BC with CNS metastases.MethodsThis multicentre, retrospective, observational study was conducted on HER2-positive BC patients diagnosed with CNS metastases between 2006 and 2008. Data were extracted from patient medical records to estimate health care resource use. A partitioned estimator was used to adjust censoring costs by use of the Kaplan-Meier survival estimate.Results218 patients were included and costs were estimated for 200 patients. The median time to detection of CNS metastases was 37.6 months. The first metastatic event involved the CNS in 39 patients, and this was the unique first metastatic site in 31 of these patients. Two years following diagnosis of CNS metastases, 70.3% of patients had died. The mean per capita cost of HER2-positive BC with CNS metastases in the first year following diagnosis was €35,735 [95% CI: 31,716-39,898]. The proportion of costs attributed to expensive drugs and those arising from hospitalisation were in the same range.ConclusionA range of individualised disease management strategies are used in HER2-positive BC patients with CNS metastases and the treatments used in the first months following diagnosis are expensive. The understanding of cost drivers may help optimise healthcare expenditure and inform the development of appropriate prevention policies.
27 schema:genre article
28 schema:isAccessibleForFree true
29 schema:isPartOf N8b51e524e5604ee8bb3c3d949eff6299
30 Nd269998640ea449e89b2076dbe1d87dc
31 sg:journal.1327417
32 schema:keywords BC patients
33 CNS
34 CNS metastases
35 HER2-positive BC patients
36 HER2-positive breast cancer
37 Kaplan-Meier survival estimates
38 MethodsThis multicentre
39 Results218 patients
40 appropriate prevention policies
41 breast cancer
42 cancer
43 capita costs
44 care costs
45 care resource use
46 central nervous system metastases
47 clinical outcomes
48 cost
49 cost drivers
50 data
51 detection
52 development
53 diagnosis
54 disease management strategies
55 drivers
56 drugs
57 epidermal growth factor receptor 2
58 estimates
59 estimator
60 events
61 expenditure
62 expensive drugs
63 factor receptor 2
64 first metastatic event
65 first metastatic site
66 first month
67 first year
68 growth factor receptor 2
69 health care costs
70 health care resource use
71 healthcare expenditures
72 hospitalisation
73 human epidermal growth factor receptor 2
74 management
75 management strategies
76 means
77 median time
78 medical records
79 metastasis
80 metastatic events
81 metastatic sites
82 months
83 multicentre
84 multicentre observational study
85 nervous system metastases
86 objective
87 observational study
88 outcomes
89 patients
90 patients' medical records
91 patterns
92 policy
93 population
94 population of patients
95 positive breast cancer
96 prevention policies
97 proportion
98 proportion of costs
99 range
100 receptor 2
101 records
102 resource use
103 same range
104 sites
105 strategies
106 study
107 survival estimates
108 time
109 treatment
110 treatment patterns
111 treatment strategies
112 understanding
113 use
114 years
115 schema:name Treatment patterns, clinical outcomes and health care costs associated with her2-positive breast cancer with central nervous system metastases: a French multicentre observational study
116 schema:pagination 456
117 schema:productId N6ca2f8fbf4374db7b0ebb8159ad60d7f
118 Nd03c7cbf81bc457ba13573e5ecf7e204
119 Nee2bd6e2cf4e49649597e2e9ed335d5e
120 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014130335
121 https://doi.org/10.1186/1472-6963-13-456
122 schema:sdDatePublished 2022-10-01T06:38
123 schema:sdLicense https://scigraph.springernature.com/explorer/license/
124 schema:sdPublisher N7a38fe33b2a64f89989b63e563f4c414
125 schema:url https://doi.org/10.1186/1472-6963-13-456
126 sgo:license sg:explorer/license/
127 sgo:sdDataset articles
128 rdf:type schema:ScholarlyArticle
129 N0000cc2f98c4441eb1a9bd6368ce5a07 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Kaplan-Meier Estimate
131 rdf:type schema:DefinedTerm
132 N0f530adf645f4c9086902a3f1dd4f18e rdf:first sg:person.0631562437.67
133 rdf:rest N33556744a2aa4c5b94c03ce3f914aca1
134 N0fce1aeb130a44588c6387a988314c74 rdf:first sg:person.01252205456.11
135 rdf:rest Ncdc3a784554b46fdb95e342741d74399
136 N1be90829d2fb49399f2fa85393115cf0 rdf:first sg:person.01136617563.27
137 rdf:rest N266584f418f94c2eb7f182a45551c304
138 N21741d53fd0d41b2b5043bb5fedd380a rdf:first sg:person.0731533007.65
139 rdf:rest Nad051554461345f8bf90c4e791300f9f
140 N24662750584445d591afeedfe071d3c7 rdf:first sg:person.0727212634.00
141 rdf:rest N1be90829d2fb49399f2fa85393115cf0
142 N266584f418f94c2eb7f182a45551c304 rdf:first sg:person.0746022136.57
143 rdf:rest Ncbc303dba5bc4ca492deaac588f19ca4
144 N2eda9e33036849509fe7fe7ca92e5ecc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Patient Outcome Assessment
146 rdf:type schema:DefinedTerm
147 N33556744a2aa4c5b94c03ce3f914aca1 rdf:first sg:person.014333462034.48
148 rdf:rest N62c00c089c85440ea13bd6e31aa9a490
149 N42a2712343a044018ab0f4f5779a0b36 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Time Factors
151 rdf:type schema:DefinedTerm
152 N46fcc627b584410998e34890c3fb05cb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Retrospective Studies
154 rdf:type schema:DefinedTerm
155 N62c00c089c85440ea13bd6e31aa9a490 rdf:first sg:person.01335025472.26
156 rdf:rest N8f47b68847c94a82b72fdfb199425a2a
157 N69b8f5f1906741f5a373ac715ed74fce rdf:first sg:person.01013525105.24
158 rdf:rest N0f530adf645f4c9086902a3f1dd4f18e
159 N6ca2f8fbf4374db7b0ebb8159ad60d7f schema:name dimensions_id
160 schema:value pub.1014130335
161 rdf:type schema:PropertyValue
162 N7a38fe33b2a64f89989b63e563f4c414 schema:name Springer Nature - SN SciGraph project
163 rdf:type schema:Organization
164 N82b5a69c69bd40c09ab30720aed3deb2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Middle Aged
166 rdf:type schema:DefinedTerm
167 N84dfed134b694e2ba5aa7f96eca3a65d rdf:first sg:person.0777101415.36
168 rdf:rest N92adc13d2faa4f70a9b0ee69f63e3c44
169 N874ced525a6541c3bab9a7816e53e5bc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Humans
171 rdf:type schema:DefinedTerm
172 N8b51e524e5604ee8bb3c3d949eff6299 schema:issueNumber 1
173 rdf:type schema:PublicationIssue
174 N8d60a8f7d29b43639bb6a18d4b7eeecd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Young Adult
176 rdf:type schema:DefinedTerm
177 N8f47b68847c94a82b72fdfb199425a2a rdf:first sg:person.01117111471.08
178 rdf:rest N0fce1aeb130a44588c6387a988314c74
179 N92adc13d2faa4f70a9b0ee69f63e3c44 rdf:first sg:person.01047403102.58
180 rdf:rest Ne5d6ad85482b479cbdf9e25d3951c2fd
181 N9c4da5f5390e467ebf651abf7373b166 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Genes, erbB-2
183 rdf:type schema:DefinedTerm
184 N9ed2cd9f107d428682a4949569201488 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Breast Neoplasms
186 rdf:type schema:DefinedTerm
187 Na4bfb33bc3d842c2ad29a363f37f570c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Aged
189 rdf:type schema:DefinedTerm
190 Nac22fd3e606d4d34b75f9396aeba0719 rdf:first sg:person.01315023242.63
191 rdf:rest N24662750584445d591afeedfe071d3c7
192 Nad051554461345f8bf90c4e791300f9f rdf:first sg:person.01310327270.45
193 rdf:rest N69b8f5f1906741f5a373ac715ed74fce
194 Ncbc303dba5bc4ca492deaac588f19ca4 rdf:first sg:person.0655344765.05
195 rdf:rest N84dfed134b694e2ba5aa7f96eca3a65d
196 Ncdc3a784554b46fdb95e342741d74399 rdf:first sg:person.01210731760.28
197 rdf:rest Nac22fd3e606d4d34b75f9396aeba0719
198 Nd03c7cbf81bc457ba13573e5ecf7e204 schema:name doi
199 schema:value 10.1186/1472-6963-13-456
200 rdf:type schema:PropertyValue
201 Nd1a71a205a6443fb9528cb24a67bdfd6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
202 schema:name Adult
203 rdf:type schema:DefinedTerm
204 Nd269998640ea449e89b2076dbe1d87dc schema:volumeNumber 13
205 rdf:type schema:PublicationVolume
206 Nd99cc0d04b934f72b49f3d73555d1906 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
207 schema:name France
208 rdf:type schema:DefinedTerm
209 Ndc855cff2c984d128fc85310a1220a13 rdf:first sg:person.01327533357.46
210 rdf:rest rdf:nil
211 Ne5d6ad85482b479cbdf9e25d3951c2fd rdf:first sg:person.01115516302.28
212 rdf:rest Ndc855cff2c984d128fc85310a1220a13
213 Ne9668abb72434c238af58c0af8edd34f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
214 schema:name Female
215 rdf:type schema:DefinedTerm
216 Nee2bd6e2cf4e49649597e2e9ed335d5e schema:name pubmed_id
217 schema:value 24176086
218 rdf:type schema:PropertyValue
219 Nf97c76774a60414d9192807f104a2581 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
220 schema:name Central Nervous System Neoplasms
221 rdf:type schema:DefinedTerm
222 Nf982149327f74558a249fdaa10e59b8b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
223 schema:name Aged, 80 and over
224 rdf:type schema:DefinedTerm
225 Nfd981e20c0fc4b488668bd8f967f9c9d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
226 schema:name Health Care Costs
227 rdf:type schema:DefinedTerm
228 Nfe65380f4d11424ca566801b35f88141 rdf:first sg:person.01002330441.34
229 rdf:rest N21741d53fd0d41b2b5043bb5fedd380a
230 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
231 schema:name Medical and Health Sciences
232 rdf:type schema:DefinedTerm
233 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
234 schema:name Oncology and Carcinogenesis
235 rdf:type schema:DefinedTerm
236 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
237 schema:name Public Health and Health Services
238 rdf:type schema:DefinedTerm
239 sg:journal.1327417 schema:issn 1472-6963
240 schema:name BMC Health Services Research
241 schema:publisher Springer Nature
242 rdf:type schema:Periodical
243 sg:person.01002330441.34 schema:affiliation grid-institutes:grid.418596.7
244 schema:familyName Baffert
245 schema:givenName Sandrine
246 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002330441.34
247 rdf:type schema:Person
248 sg:person.01013525105.24 schema:affiliation grid-institutes:None
249 schema:familyName Mercier
250 schema:givenName Florence
251 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013525105.24
252 rdf:type schema:Person
253 sg:person.01047403102.58 schema:affiliation grid-institutes:None
254 schema:familyName Maillard
255 schema:givenName Cathie
256 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047403102.58
257 rdf:type schema:Person
258 sg:person.01115516302.28 schema:affiliation grid-institutes:None
259 schema:familyName Laulhere-Vigneau
260 schema:givenName Sabine
261 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01115516302.28
262 rdf:type schema:Person
263 sg:person.01117111471.08 schema:affiliation grid-institutes:grid.476192.f
264 schema:familyName Levy
265 schema:givenName Christelle
266 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01117111471.08
267 rdf:type schema:Person
268 sg:person.01136617563.27 schema:affiliation grid-institutes:None
269 schema:familyName Spaëth
270 schema:givenName Dominique
271 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01136617563.27
272 rdf:type schema:Person
273 sg:person.01210731760.28 schema:affiliation grid-institutes:grid.476460.7
274 schema:familyName Madranges
275 schema:givenName Nicolas
276 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210731760.28
277 rdf:type schema:Person
278 sg:person.01252205456.11 schema:affiliation grid-institutes:grid.418596.7
279 schema:familyName Gutierrez
280 schema:givenName Maya
281 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252205456.11
282 rdf:type schema:Person
283 sg:person.01310327270.45 schema:affiliation grid-institutes:grid.418596.7
284 schema:familyName Kirova
285 schema:givenName Youlia M
286 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310327270.45
287 rdf:type schema:Person
288 sg:person.01315023242.63 schema:affiliation grid-institutes:grid.418189.d
289 schema:familyName Moldovan
290 schema:givenName Cristian
291 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01315023242.63
292 rdf:type schema:Person
293 sg:person.01327533357.46 schema:affiliation grid-institutes:grid.412116.1
294 schema:familyName Durand-Zaleski
295 schema:givenName Isabelle
296 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327533357.46
297 rdf:type schema:Person
298 sg:person.01335025472.26 schema:affiliation grid-institutes:grid.410463.4
299 schema:familyName Le Rhun
300 schema:givenName Emilie
301 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01335025472.26
302 rdf:type schema:Person
303 sg:person.014333462034.48 schema:affiliation grid-institutes:grid.418116.b
304 schema:familyName Bachelot
305 schema:givenName Thomas
306 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014333462034.48
307 rdf:type schema:Person
308 sg:person.0631562437.67 schema:affiliation grid-institutes:grid.418596.7
309 schema:familyName Simondi
310 schema:givenName Cécile
311 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0631562437.67
312 rdf:type schema:Person
313 sg:person.0655344765.05 schema:affiliation grid-institutes:grid.476503.3
314 schema:familyName Cotté
315 schema:givenName François-Emery
316 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0655344765.05
317 rdf:type schema:Person
318 sg:person.0727212634.00 schema:affiliation grid-institutes:None
319 schema:familyName Coudert
320 schema:givenName Bruno
321 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727212634.00
322 rdf:type schema:Person
323 sg:person.0731533007.65 schema:affiliation grid-institutes:grid.418596.7
324 schema:familyName Cottu
325 schema:givenName Paul
326 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0731533007.65
327 rdf:type schema:Person
328 sg:person.0746022136.57 schema:affiliation grid-institutes:grid.482015.a
329 schema:familyName Serin
330 schema:givenName Daniel
331 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0746022136.57
332 rdf:type schema:Person
333 sg:person.0777101415.36 schema:affiliation grid-institutes:grid.476503.3
334 schema:familyName Benjamin
335 schema:givenName Laure
336 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0777101415.36
337 rdf:type schema:Person
338 sg:pub.10.1007/s10549-005-9034-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049624536
339 https://doi.org/10.1007/s10549-005-9034-6
340 rdf:type schema:CreativeWork
341 sg:pub.10.1007/s10549-007-9601-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050250912
342 https://doi.org/10.1007/s10549-007-9601-0
343 rdf:type schema:CreativeWork
344 sg:pub.10.1038/bjc.2011.531 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016621851
345 https://doi.org/10.1038/bjc.2011.531
346 rdf:type schema:CreativeWork
347 grid-institutes:None schema:alternateName Ceri Medical, Garches, France
348 Department of Medical Oncology, Centre JF Leclerc, Dijon, France
349 Department of Medical Oncology, Centre d’Oncologie de Gentilly, Nancy, France
350 Stat Process, Port-Mort, France
351 schema:name Ceri Medical, Garches, France
352 Department of Medical Oncology, Centre JF Leclerc, Dijon, France
353 Department of Medical Oncology, Centre d’Oncologie de Gentilly, Nancy, France
354 Stat Process, Port-Mort, France
355 rdf:type schema:Organization
356 grid-institutes:grid.410463.4 schema:alternateName Neurology, Medical Oncology Department, Oscar Lambret Center, Lille, France and Neuro-oncology, University Hospital, Lille, France
357 schema:name Neurology, Medical Oncology Department, Oscar Lambret Center, Lille, France and Neuro-oncology, University Hospital, Lille, France
358 rdf:type schema:Organization
359 grid-institutes:grid.412116.1 schema:alternateName Hôpital Henri-Mondor, Créteil, France
360 schema:name Hôpital Henri-Mondor, Créteil, France
361 rdf:type schema:Organization
362 grid-institutes:grid.418116.b schema:alternateName Department of Medical Oncology, Centre Léon Bérard, Lyon, France
363 schema:name Department of Medical Oncology, Centre Léon Bérard, Lyon, France
364 rdf:type schema:Organization
365 grid-institutes:grid.418189.d schema:alternateName Department of Medical Oncology, Centre Henri Becquerel, Rouen, France
366 schema:name Department of Medical Oncology, Centre Henri Becquerel, Rouen, France
367 rdf:type schema:Organization
368 grid-institutes:grid.418596.7 schema:alternateName Department of Clinical Research, Institut Curie, Paris, France
369 Department of Medical Oncology, Institut Curie, Paris, France
370 Department of Medical Oncology, Institut Curie, Saint-Cloud, France
371 Department of Public Health, Health Economics unit, Institut Curie, 26 rue d’Ulm, 75005, Paris, France
372 Department of Radiation Oncology, Institut Curie, Paris, France
373 schema:name Department of Clinical Research, Institut Curie, Paris, France
374 Department of Medical Oncology, Institut Curie, Paris, France
375 Department of Medical Oncology, Institut Curie, Saint-Cloud, France
376 Department of Public Health, Health Economics unit, Institut Curie, 26 rue d’Ulm, 75005, Paris, France
377 Department of Radiation Oncology, Institut Curie, Paris, France
378 rdf:type schema:Organization
379 grid-institutes:grid.476192.f schema:alternateName Department of Medical Oncology, Centre François Baclesse, Caen, France
380 schema:name Department of Medical Oncology, Centre François Baclesse, Caen, France
381 rdf:type schema:Organization
382 grid-institutes:grid.476460.7 schema:alternateName Department of Medical Oncology, Institut Bergonié, Bordeaux, France
383 schema:name Department of Medical Oncology, Institut Bergonié, Bordeaux, France
384 rdf:type schema:Organization
385 grid-institutes:grid.476503.3 schema:alternateName Department of Pharmaco-Epidemiology and Health Outcomes Research, GlaxoSmithKline, Marly-le-Roi, France
386 schema:name Department of Pharmaco-Epidemiology and Health Outcomes Research, GlaxoSmithKline, Marly-le-Roi, France
387 rdf:type schema:Organization
388 grid-institutes:grid.482015.a schema:alternateName Department of Medical Oncology, Institut Sainte Catherine, Avignon, France
389 schema:name Department of Medical Oncology, Institut Sainte Catherine, Avignon, France
390 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...